Cafepharma Today

January 27 2025 - Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Metsera eyes $289M IPO to fund phase 3 weight loss trial
Biogen, Eisai win nod for monthly Leqembi maintenance amid stagnant sales
Sara Brenner, FDA device official, named agency’s acting head
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Moderna stock plunges nearly 17% after company lowers 2025 sales forecast by $1 billion
CNBC
Monday, January 13, 2025 - 5:43pm
tags:
Moderna Therapeutics
Onera’s validation trial of home polysomnography sleep device succeeds
Clinical Trials Arena
Monday, January 13, 2025 - 5:41pm
tags:
Medtech, polysomnography, sleep diagnostics, Onera, clinical trials
Broader population could benefit from Novartis spinal muscular atrophy treatment
Clinical Trials Arena
Monday, January 13, 2025 - 5:39pm
tags:
Novartis, SMA, OAV101 IT
Why Madrigal stock is sinking today
Motley Fool
Monday, January 13, 2025 - 5:38pm
tags:
Madrigal Pharmaceuticals, earnings
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Investing.com
Monday, January 13, 2025 - 5:37pm
tags:
JPMHC 2025, obesity, Pharma CEOs, Albert Bourla
J&J to buy psychiatric drug developer Intra-Cellular for $14.6B
BioPharma Dive
Monday, January 13, 2025 - 11:19am
tags:
JNJ, Intra-Cellular Therapies, JPMHC 2025, M&A, psychiatric disease
JPM25: Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard of care
Fierce Biotech
Monday, January 13, 2025 - 11:18am
tags:
GSK, JPMHC 2025, IDRx, GIST, cancer, precision medicine
The ability to pivot will be ‘key’ as pharma’s tariff threat looms
Pharma Voice
Monday, January 13, 2025 - 11:16am
tags:
Donald Trump, tariffs, China, Mexico, drug pricing
Purdue's Sacklers offer to increase contribution in new opioid settlement, WSJ reports
US News and World Report
Monday, January 13, 2025 - 11:15am
tags:
Purdue Pharma, legal, Sackler family, bankruptcy, opioids, opioid crisis
JPM25: Bayer moves allogeneic cell therapy into phase 3 Parkinson's trial
Fierce Biotech
Monday, January 13, 2025 - 11:13am
tags:
Bayer, JPMHC 2025, cell therapy, Parkinson's Disease, clinical trials
JPM25: AbbVie pens $1B deal for Simcere’s phase 1 T-cell engager
Fierce Biotech
Monday, January 13, 2025 - 11:11am
tags:
AbbVie, JPMHC 2025, Simcere, T-cell engager
Pfizer’s Phase III bladder cancer therapy trial meets primary endpoint
Clinical Trials Arena
Monday, January 13, 2025 - 11:10am
tags:
Pfizer, clinical trials, bladder cancer, sasanlimab, BCG
New Acquisition to Strengthen Lantheus’s Position in Alzheimer’s Radiodiagnostic Market
Medical Devices and Diagnostics Industry
Monday, January 13, 2025 - 11:08am
tags:
Lantheus, Medtech, M&A, Life Molecular, Alzheimer's disease
2024 was a record year for obesity trials and 2025 is already poised to take over
Clinical Trials Arena
Monday, January 13, 2025 - 11:07am
tags:
clinical trials, obesity
Gilead roars into JPM25, inking $1.7B inflammation deal with Leo Pharma
Fierce Biotech
Monday, January 13, 2025 - 11:03am
tags:
Gilead Sciences, JPMHC 2025, LEO Pharma, inflammation
Kailera reports Zepbound-rivaling weight loss in phase 2 obesity trial
Fierce Biotech
Monday, January 13, 2025 - 11:01am
tags:
Kailera Therapuetics, obesity, clinical trials, Jiangsu Hengrui Pharmaceuticals
Lilly pads cancer drug pipeline with Scorpion deal
BioPharma Dive
Monday, January 13, 2025 - 11:00am
tags:
Eli Lilly, Scorpion Therapeutics, STX-678, cancer
Sage Therapeutics Stock Soars as Biogen Makes Unsolicited Takeover Bid
Yahoo/Investopedia
Monday, January 13, 2025 - 10:54am
tags:
SAGE Therapeutics, Biogen, M&A
5 questions facing pharma in 2025
BioPharma Dive
Friday, January 10, 2025 - 11:47am
tags:
Donald Trump, obesity, Novo Nordisk, Eli Lilly, vaccines, pharma stocks, regulatory, immunology
Fueled by new launches, US drug prices poised to continue trending upward: Cowen report
Fierce Pharma
Friday, January 10, 2025 - 11:41am
tags:
drug pricing, drug launches

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels
2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information